Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03370185 |
| Title | Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma |
| Acronym | BRIO |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Verastem, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Arizona Oncology | Tempe | Arizona | 85284 | United States | Details | |
| Genesis Cancer Center | Hot Springs | Arkansas | 71913 | United States | Details | |
| Moores UC San Diego Cancer Center | La Jolla | California | 92093 | United States | Details | |
| Ingalls Memorial Hospital | Harvey | Illinois | 60426 | United States | Details | |
| QUEST Research Institute | Royal Oak | Michigan | 48073 | United States | Details | |
| St. Vincent Frontier Cancer Center | Billings | Montana | 59102 | United States | Details | |
| Summit Medical Group | Morristown | New Jersey | 07932 | United States | Details | |
| Medical Oncology Associates PS, WA | Spokane | Washington | 99208 | United States | Details |